216 related articles for article (PubMed ID: 18227806)
1. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
[TBL] [Abstract][Full Text] [Related]
2. Deimination of myelin basic protein. 2. Effect of methylation of MBP on its deimination by peptidylarginine deiminase.
Pritzker LB; Joshi S; Harauz G; Moscarello MA
Biochemistry; 2000 May; 39(18):5382-8. PubMed ID: 10820009
[TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.
Musse AA; Li Z; Ackerley CA; Bienzle D; Lei H; Poma R; Harauz G; Moscarello MA; Mastronardi FG
Dis Model Mech; 2008; 1(4-5):229-40. PubMed ID: 19093029
[TBL] [Abstract][Full Text] [Related]
4. Deimination of human myelin basic protein by a peptidylarginine deiminase from bovine brain.
Lamensa JW; Moscarello MA
J Neurochem; 1993 Sep; 61(3):987-96. PubMed ID: 7689646
[TBL] [Abstract][Full Text] [Related]
5. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D.
Pritzker LB; Joshi S; Gowan JJ; Harauz G; Moscarello MA
Biochemistry; 2000 May; 39(18):5374-81. PubMed ID: 10820008
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis.
Jang B; Kim E; Choi JK; Jin JK; Kim JI; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
Am J Pathol; 2008 Oct; 173(4):1129-42. PubMed ID: 18787103
[TBL] [Abstract][Full Text] [Related]
7. Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).
Bonilha VL; Shadrach KG; Rayborn ME; Li Y; Pauer GJ; Hagstrom SA; Bhattacharya SK; Hollyfield JG
Exp Eye Res; 2013 Jun; 111():71-8. PubMed ID: 23562679
[TBL] [Abstract][Full Text] [Related]
8. Peptidylarginine deiminase: a candidate factor in demyelinating disease.
Moscarello MA; Pritzker L; Mastronardi FG; Wood DD
J Neurochem; 2002 Apr; 81(2):335-43. PubMed ID: 12064481
[TBL] [Abstract][Full Text] [Related]
9. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
[TBL] [Abstract][Full Text] [Related]
10. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice.
van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ
Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755
[TBL] [Abstract][Full Text] [Related]
11. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.
Liu Y; Lightfoot YL; Seto N; Carmona-Rivera C; Moore E; Goel R; O'Neil L; Mistry P; Hoffmann V; Mondal S; Premnath PN; Gribbons K; Dell'Orso S; Jiang K; Thompson PR; Sun HW; Coonrod SA; Kaplan MJ
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518690
[TBL] [Abstract][Full Text] [Related]
13. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
14. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
Wang Y; Chen R; Gan Y; Ying S
Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
[TBL] [Abstract][Full Text] [Related]
15. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
16. Expression of peptidylarginine deiminase 4 in an alkali injury model of retinal gliosis.
Wizeman JW; Mohan R
Biochem Biophys Res Commun; 2017 May; 487(1):134-139. PubMed ID: 28400047
[TBL] [Abstract][Full Text] [Related]
17. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.
Mastronardi FG; Wood DD; Mei J; Raijmakers R; Tseveleki V; Dosch HM; Probert L; Casaccia-Bonnefil P; Moscarello MA
J Neurosci; 2006 Nov; 26(44):11387-96. PubMed ID: 17079667
[TBL] [Abstract][Full Text] [Related]
18. Delayed puberty, gonadotropin abnormalities and subfertility in male Padi2/Padi4 double knockout mice.
Sams KL; Mukai C; Marks BA; Mittal C; Demeter EA; Nelissen S; Grenier JK; Tate AE; Ahmed F; Coonrod SA
Reprod Biol Endocrinol; 2022 Oct; 20(1):150. PubMed ID: 36224627
[TBL] [Abstract][Full Text] [Related]
19. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
Ishigami A; Ohsawa T; Hiratsuka M; Taguchi H; Kobayashi S; Saito Y; Murayama S; Asaga H; Toda T; Kimura N; Maruyama N
J Neurosci Res; 2005 Apr; 80(1):120-8. PubMed ID: 15704193
[TBL] [Abstract][Full Text] [Related]
20. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
